News & Press: Latest News

MDMA Statement on the Nomination of Scott Gottlieb to Lead the FDA

Friday, March 10, 2017  
Share |
MDMA Statement on the Nomination of Scott Gottlieb to Lead the FDA

WASHINGTON, DC -- Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement regarding Dr. Scott Gottlieb’s nomination as the next commissioner of the Food and Drug Administration (FDA):

“Dr. Gottlieb is a leading expert on fostering medical technology innovations, and MDMA congratulates him on his nomination to be the next FDA Commissioner.  He has dedicated his career to helping patients, and has shaped policies that improve access to lifesaving and life changing treatments.

“While the United States remains the global leader in medical technology innovation, there is still much more work to be done.  Dr. Gottlieb has a proud history of guiding the FDA towards improvements that result in better patient care and lower overall costs to the system, and as a physician he has a unique insight on how all stakeholders can work together to achieve our common goals.

“If approved by the Senate, MDMA looks forward to working with him to ensure that patients have timely access to safe and effective medical technologies, and that the United States continues to lead the world in solving the challenges facing the health care ecosystem.”